Yongin, South Korea

Chong Hwan Cho

This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Dong-A Pharm. Co., Ltd., Dong-A Pharmaceuticals Co. Ltd., Dong-A St Co., Ltd.. Active years: 2010-2015.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Chong Hwan Cho

Introduction

Chong Hwan Cho is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with antibacterial properties. With a total of four patents to his name, his work has the potential to impact medical treatments significantly.

Latest Patents

One of his latest patents involves oxazolidinone derivatives. This invention relates to novel derivatives of oxazolidinone, a method thereof, and pharmaceutical compositions comprising these derivatives for use in antibiotics. The oxazolidinone derivatives demonstrate inhibitory activity against a broad spectrum of bacteria while exhibiting lower toxicity. Additionally, prodrugs prepared by reacting compounds with hydroxyl groups with amino acids or phosphates show excellent solubility in water. These derivatives may exert potent antibacterial activity against various human and animal pathogens, including Gram-positive bacteria, anaerobic microorganisms, and acid-resistant microorganisms. Consequently, the compositions containing oxazolidinone are utilized in antibiotic applications.

Another significant patent focuses on herbal extracts, specifically those derived from Semen, Tuber, and Seed. This invention relates to a composition containing these extracts for treating and preventing gastrointestinal motility disorders. The extracts have shown remarkable effects in promoting gastrointestinal motility through HT receptor antagonism.

Career Highlights

Chong Hwan Cho has worked with reputable companies in the pharmaceutical industry, including Dong-a Pharm Co., Ltd. and Dong-a Pharmaceuticals Co. Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Throughout his career, he has collaborated with notable colleagues such as Jae Keol Rhee and Tae Ho Lee. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Chong Hwan Cho's contributions to pharmaceutical innovations, particularly in antibiotic development and gastrointestinal treatments, highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…